Cite
HARVARD Citation
Jabbour, E. et al. (2018). Chemoimmunotherapy with inotuzumab ozogamicin combined with mini‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage. Cancer. 124 (20), pp. 4044-4055. [Online].